Edap Tms SA
EDAP1.287USD
-0.013-1.02%
Market hours （ET）Quotes delayed by 15 min
48.11MMarket Cap
LossP/E TTM
More Details of Edap Tms SA Company
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Company Info
Ticker SymbolEDAP
Company nameEdap Tms SA
IPO dateAug 01, 1997
CEOJean-Francois Bachelard
Number of employees310
Security typeDepository Receipt
Fiscal year-endAug 01
Address4, rue du Dauphine
CityVAULX-EN-VELIN
Stock exchangeNASDAQ Global Market Consolidated
CountryFrance
Postal code69120
Phone33472153150
Websitehttps://focalone.com/fr/accueil/
Ticker SymbolEDAP
IPO dateAug 01, 1997
CEOJean-Francois Bachelard
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Ken Mobeck
Mr. Ken Mobeck
Global Chief Financial Officer
Global Chief Financial Officer
--
--
Dr. Lance Willsey
Dr. Lance Willsey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Dr. Marie-Helene Meynadier
Dr. Marie-Helene Meynadier
Independent Director
Independent Director
--
--
Mr. Pierre Beysson, CPA
Mr. Pierre Beysson, CPA
Independent Director
Independent Director
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Global Chief Accounting Officer
Global Chief Accounting Officer
--
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
--
--
Ms. Blandine Confort
Ms. Blandine Confort
IR Contact Officer
IR Contact Officer
--
--
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ken Mobeck
Mr. Ken Mobeck
Global Chief Financial Officer
Global Chief Financial Officer
--
--
Dr. Lance Willsey
Dr. Lance Willsey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
Dr. Marie-Helene Meynadier
Dr. Marie-Helene Meynadier
Independent Director
Independent Director
--
--
Mr. Pierre Beysson, CPA
Mr. Pierre Beysson, CPA
Independent Director
Independent Director
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Global Chief Accounting Officer
Global Chief Accounting Officer
--
--
Revenue Breakdown
Currency: EURUpdated: Sun, Jul 6
Currency: EURUpdated: Sun, Jul 6
FY2024
No Data
By RegionEUR
Name
Revenue
Proportion
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
By Business
By Region
No Data
Shareholding Stats
Updated: Thu, Jul 24
Updated: Thu, Jul 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
9.00%
Rock Springs Capital Management LP
3.40%
Dubly Transatlantique Gestion
1.95%
Bruce & Company, Inc.
1.48%
Other
64.63%
Shareholders
Shareholders
Proportion
Soleus Capital Management, L.P.
19.55%
Morgan Stanley & Co. International Plc
9.00%
Rock Springs Capital Management LP
3.40%
Dubly Transatlantique Gestion
1.95%
Bruce & Company, Inc.
1.48%
Other
64.63%
Shareholder Types
Shareholders
Proportion
Hedge Fund
27.23%
Research Firm
9.12%
Investment Advisor
4.88%
Investment Advisor/Hedge Fund
0.23%
Other
58.54%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
83
15.50M
41.46%
-2.31M
2025Q1
89
15.47M
41.38%
-2.38M
2024Q4
92
15.39M
41.47%
-2.59M
2024Q3
91
15.67M
42.24%
-3.03M
2024Q2
88
16.06M
43.28%
-2.91M
2024Q1
94
16.22M
43.72%
-3.26M
2023Q4
91
15.98M
43.08%
-4.16M
2023Q3
94
15.98M
43.28%
-3.85M
2023Q2
97
16.26M
44.04%
-2.56M
2023Q1
99
14.83M
40.17%
-3.58M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Soleus Capital Management, L.P.
7.31M
19.55%
--
--
Mar 31, 2025
Morgan Stanley & Co. International Plc
3.36M
9%
-3.01K
-0.09%
Mar 31, 2025
Rock Springs Capital Management LP
1.27M
3.4%
-321.80K
-20.22%
Mar 31, 2025
Dubly Transatlantique Gestion
730.70K
1.95%
+720.50K
+7063.72%
Mar 31, 2025
Bruce & Company, Inc.
553.65K
1.48%
--
--
Mar 31, 2025
Apis Capital Advisors LLC
524.00K
1.4%
+5.00K
+0.96%
Mar 31, 2025
Scoggin Management LP
350.00K
0.94%
+350.00K
--
Mar 31, 2025
Archon Capital Management LLC
273.61K
0.73%
-709.07K
-72.16%
Mar 31, 2025
Schonfeld Strategic Advisors LLC
166.43K
0.45%
+5.63K
+3.50%
Mar 31, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
